184 related articles for article (PubMed ID: 9165632)
1. Pharmacotherapy of schizophrenia patients with comorbid substance abuse.
Wilkins JN
Schizophr Bull; 1997; 23(2):215-28. PubMed ID: 9165632
[TBL] [Abstract][Full Text] [Related]
2. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia.
Hamera E; Schneider JK; Deviney S
J Nerv Ment Dis; 1995 Sep; 183(9):559-65. PubMed ID: 7561817
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with flupenthixol decanoate of a patient with both schizophrenia and alcoholism.
Soyka M; Sand P
Pharmacopsychiatry; 1995 Mar; 28(2):64-5. PubMed ID: 7624388
[TBL] [Abstract][Full Text] [Related]
4. Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients.
Krystal JH; D'Souza DC; Madonick S; Petrakis IL
Schizophr Res; 1999 Mar; 35 Suppl():S35-49. PubMed ID: 10190224
[TBL] [Abstract][Full Text] [Related]
5. Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome.
Werner FM; Covenas R
Curr Drug Abuse Rev; 2017; 10(1):19-24. PubMed ID: 29065847
[TBL] [Abstract][Full Text] [Related]
6. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia.
Buckley PF
J Subst Abuse Treat; 1998; 15(2):113-6. PubMed ID: 9561949
[TBL] [Abstract][Full Text] [Related]
7. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
Thoma P; Daum I
Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
[TBL] [Abstract][Full Text] [Related]
8. Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence.
Soyka M; De Vry J
Eur Neuropsychopharmacol; 2000 Sep; 10(5):325-32. PubMed ID: 10974602
[TBL] [Abstract][Full Text] [Related]
9. [Anesthesiological management of the drug-abusing parturient: relevance of maternal substance abuse for obstetric anesthesia].
Kork F; Kleinwächter R; Kaufner L; Weib-Gerlach E; Siedentopf JP; Spies C
Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Oct; 46(10):640-6. PubMed ID: 22020568
[TBL] [Abstract][Full Text] [Related]
10. [Flupenthixol--a partial atypical neuroleptic?].
Kühn KU; Meyer K; Maier W
Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S38-41. PubMed ID: 10907612
[TBL] [Abstract][Full Text] [Related]
11. Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics.
Scheller-Gilkey G; Woolwine BJ; Cooper I; Gay O; Moynes KA; Miller AH
Am J Drug Alcohol Abuse; 2003 Aug; 29(3):553-66. PubMed ID: 14510040
[TBL] [Abstract][Full Text] [Related]
12. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
Potvin S; Stip E; Roy JY
Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for schizophrenia and co-occurring substance use disorders.
Green AI
Neurotox Res; 2007 Jan; 11(1):33-40. PubMed ID: 17449446
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics.
Ziedonis D; Richardson T; Lee E; Petrakis I; Kosten T
Psychopharmacol Bull; 1992; 28(3):309-14. PubMed ID: 1480735
[TBL] [Abstract][Full Text] [Related]
15. Substance abuse and schizophrenia: editors' introduction.
Kosten TR; Ziedonis DM
Schizophr Bull; 1997; 23(2):181-6. PubMed ID: 9165628
[TBL] [Abstract][Full Text] [Related]
16. [Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia].
Lisoprawski A
Sem Hop; 1983 Jun; 59(25):1925-7. PubMed ID: 6136096
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
Green AI
J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
[TBL] [Abstract][Full Text] [Related]
18. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
19. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?
Green AI; Zimmet SV; Strous RD; Schildkraut JJ
Harv Rev Psychiatry; 1999; 6(6):287-96. PubMed ID: 10370435
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
